Obama care… good or bad for pharma

A new Price Waterhouse study says Obamacare is a net negative for pharma…

Despite the additional uninsured gaining insurance coverage and despite PhRMAs negotiations averting disasters such as drug re-importation, the study says the numbers still add up to a net loss for pharma. What do you think?